Identification of CD68+ neutrophil granulocytes in in vitro model of acute inflammation and inflammatory bowel disease
Introduction: CD-68 is widely regarded as a selective marker for human monocytes and macrophages and is commonly used in human pathology studies. The purpose of this study was to investigate the expression of CD-68 in human peripheral blood mononuclear cells (PBMCs), neutrophil granulocytes (NGs) and in inflamed intestinal tissue samples for comparison.
Material and methods: PBMCs and NGs were isolated from heparinized human blood samples. Intestinal biopsies were obtained during routine endoscopic procedures from patients with inflammatory bowel disease (IBD), e.g. ulcerative colitis and Crohn's disease. Gene and protein expression was analyzed by real-time RT-PCR, Western blot and immunohistochemistry.
Results: Both PBMCs and NGs preparations contained cells that were positive for CD-68 and either neutrophil elastase (NE), or myeloperoxidase (MPO). CD-68+/NE-/MPO- cells were regarded as monocytes. CD-68 mRNA expression was detected in PBMCs and NGs preparations. With Western blot and by performing immunoprecipitation of cell lysate, we could clearly detect CD-68 in NGs, U-937, THP-1, Hep-G2, Jurkat cells and PBMCs. Identification of inflammatory cells in acutely inflamed colonic mucosa obtained from patients with IBD revealed a strong accumulation of CD-68+/MPO+ cells compared to normal colonic mucosa. The uptake of the marker by phagocytosis was excluded by performing a double staining with CD-163/NE and CD-163/MPO in PBMCs, NGs cultures and in inflamed colonic mucosa.
Discussion: In conclusion, this study identifies CD-68 as a marker for NGs and macrophages-monocytes in peripheral blood and acutely inflamed colonic mucosa of patients with inflammatory bowel diseases. The observation that different types of non-macrophage-like cells express the “macrophage” marker CD-68 clearly means that these “macrophage-like” cells are a distinct cell population which could play an important role during an acute flare in patients with Crohn's disease or ulcerative colitis and have to be more thoroughly identified using other cell type-specific markers and the appropriate technique and fixation.